BEXSERO susp inj ser pré 0.5 ml

7680657300031 CH-65730 J07AH09 08.08.

Reimbursement limitations:

0808 NEU

La prise en charge des coûts des vaccins au titre de mesure préventive dans le …

BEXSERO susp inj ser pré 0.5 ml
BEXSERO susp inj ser pré 0.5 ml
BEXSERO susp inj ser pré 0.5 ml
1 / 3
google

Details

Product number
6573001
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
proteinum fusionatum NHBA neisseriae meningitidis B 50 µg, proteinum NadA neisseriae meningitidis B 50 µg, proteinum fusionatum fHbp neisseriae meningitidis B 50 µg, vesicula membranae exterioris (OMV) ex Neisseria meningitidis B (Stamm: NZ98/254) 25 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, histidinum, natrii chloridum, saccharum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.2 mg.

Articles (1)

Bexsero, Injektionssuspension
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/06/2025
Professional SmPC
Français
26/06/2025
Professional SmPC
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.2 MG Substance HBESI

Reimbursement information

Public price
CHF 101.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
65730
Drug name
Bexsero, Injektionssuspension
Galenic form
INJFS
ATC Code
J07AH09
Authorization status
Z
Dispensation category
B
First authorization
23/11/2017
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken-Meningitis der Serogruppe B

Packaging details

Description (FR)
BEXSERO susp inj ser pré 0.5 ml
Description (DE)
BEXSERO Inj Susp Fertspr 0.5 ml
Market launch
23/11/2017
Narcotic (BTM)
No

Other packaging sizes